Company news
Establishment Labs Holdings Inc. news in 2024
Establishment Labs Holdings Inc.'s news releases, calls and decks from 2024, newest first.
Establishment Labs Announces Participation in Upcoming Investment Conferences
November 10, 2024
Establishment Labs Reports Third Quarter 2024 Financial Results
November 6, 2024
Establishment Labs Announces $50 Million Registered Direct Offering
November 6, 2024
Establishment Labs Announces Three-Year Mia Femtech Clinical Results at 9th World Symposium on Ergonomic Implants
October 30, 2024
Establishment Labs to Announce Third Quarter 2024 Financial Results on November 7
October 23, 2024
Establishment Labs Publishes 2024 Post Market Surveillance Report
October 14, 2024
First U.S. Women Successfully Receive Breast Augmentation with New FDA Approved Motiva Implants
October 1, 2024
Establishment Labs Receives U.S. FDA Approval for Motiva Implants
September 25, 2024
Establishment Labs Reports Second Quarter 2024 Financial Results
August 5, 2024
Establishment Labs to Announce Second Quarter 2024 Financial Results on August 6
July 23, 2024
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
May 22, 2024
Establishment Labs Reports First Quarter 2024 Financial Results
May 7, 2024
Establishment Labs Notes Presentation of 4-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2024
May 1, 2024
Establishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America
April 30, 2024
Establishment Labs to Announce First Quarter 2024 Financial Results on May 8
April 23, 2024
Establishment Labs Announces Participation in The Aesthetic Meeting 2024
April 16, 2024
Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
February 27, 2024
Establishment Labs Announces Amended Credit Facility with Oaktree
February 21, 2024
Establishment Labs to Announce Fourth Quarter 2023 Financial Results on February 28
February 13, 2024
Establishment Labs Announces Commercial Launch of Motiva Implants in China
January 21, 2024
Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023
January 8, 2024
Establishment Labs Announces First U.S. Commercial Procedure with Motiva Flora Tissue Expander
January 1, 2024